Moreover, PDA CD73 was shown to correlate with a decrease in CD4+, CD8+ and CD21+ tumor-infiltrating lymphocytes suggesting it plays an important role in immunosuppression and tumor progression (11, 12). The gene discussed is NT5E; the disease is Patent ductus arteriosus.